Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial. (2024). International Journal of Integrated Health Sciences, 12(1), 55-64. https://doi.org/10.15850/ijihs.v12.n1.3570